Varubi and Fall - a phase IV clinical study of FDA data

Summary:

Fall is reported as a side effect among people who take Varubi (rolapitant hydrochloride), especially for people who are male, 60+ old, also take Xpovio, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Fall when taking Varubi. It is created by eHealthMe based on reports of 572 people who have side effects when taking Varubi from the FDA, and is updated regularly.

What is Varubi?

Varubi has active ingredients of rolapitant hydrochloride. eHealthMe is studying from 572 Varubi users. Check the latest studies of Varubi.

What is Fall?

Fall is found to be associated with 3,292 drugs and 3,759 conditions by eHealthMe. Check the latest studies of Fall.



On Feb, 12, 2026

572 people reported to have side effects when taking Varubi.
Among them, 8 people (1.4%) have Fall.

Could Varubi cause Fall?

Among these 8 people:

What is the gender of people who have Fall when taking Varubi? *

  • female: 20 %
  • male: 80 %

What is the age of people who have Fall when taking Varubi? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Varubi? *

  1. Xpovio: 4 people, 50.00%
  2. Zyprexa: 3 people, 37.50%
  3. Pomalyst: 3 people, 37.50%
  4. Ondansetron: 3 people, 37.50%
  5. Norco: 2 people, 25.00%
  6. Pantoprazole: 2 people, 25.00%
  7. Morphine Sulfate: 2 people, 25.00%
  8. Aprepitant: 2 people, 25.00%
  9. Revlimid: 2 people, 25.00%
  10. Potassium Chloride: 2 people, 25.00%

What are other side effects people have besides Fall? *

  1. Gait Disturbance: 2 people, 25.00%
  2. Pneumonia: 2 people, 25.00%
  3. Death: 2 people, 25.00%
  4. Nausea (feeling of having an urge to vomit): 2 people, 25.00%
  5. Joint Pain: 2 people, 25.00%
  6. Hip Fracture: 2 people, 25.00%
  7. Urinary Tract Infection: 1 person, 12.50%
  8. Abdominal Pain: 1 person, 12.50%
  9. Bacteraemia (presence of bacteria in the blood): 1 person, 12.50%
  10. Blood Disorder: 1 person, 12.50%

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 4 people, 50.00%
  2. Nausea And Vomiting: 3 people, 37.50%
  3. Nausea (feeling of having an urge to vomit): 3 people, 37.50%
  4. Ovarian Cancer (cancer of ovary): 1 person, 12.50%
  5. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Varubi and have Fall?

- Check whether Fall is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Varubi:

Fall treatments and more:

  • Fall (403,513 reports)

How severe was Fall and when was it recovered:

Expand to all the drugs that have ingredients of rolapitant hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Varubi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fall:

  • Fall (3,292 drugs)

Browse all the conditions that are associated with Fall:

  • Fall (3,759 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rolapitant hydrochloride (the active ingredients of Varubi) and Varubi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: